1
Multiple Dose Study of DS-1971a
Condition(s):HealthyLast Updated:December 24, 2018Completed
DS-1971a as an Intervention: 7 Clinical Trials
Hide Studies Not Open or Pending
2
Relative Bioavailability DS-1971a Suspension and Tablets and Food Effect on DS-1971a Tablets
Condition(s):HealthyLast Updated:December 24, 2018Completed
3
Effects of Age, Gender & Race on the Pharmacokinetics (PK)of DS-1971a
Condition(s):HealthyLast Updated:December 24, 2018Completed
4
Multiple Dose Study of D1971a in Healthy Volunteers
Condition(s):HealthyLast Updated:April 28, 2017Completed
5
Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)
Condition(s):Neuropathic Pain; DiabetesLast Updated:July 27, 2016Withdrawn
6
A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS
Condition(s):HealthyLast Updated:November 5, 2015Completed
7
Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants.
Condition(s):Safety; Tolerability; PharmacokineticsLast Updated:December 24, 2018Completed